Michael Thomas

Michael Thomas serves as the Chief Executive Officer at Appian Partners, LLC, a fractional C-Suite consulting firm excelling in venture capital and private equity turnarounds since June 2009. Concurrently, Michael holds multiple leadership positions, including Sr. Commercialization Advisor for the NobleReach Foundation, managing a portfolio of DARPA-funded healthcare technology companies. As CEO at Echelon MedTech LLC and Managing Partner at Bold Brain Capital, Michael contributes to innovative solutions in medical technology and artificial intelligence. Additional roles include Director and CEO of Tanzen Medical, Executive Commercialization Consultant at ARPA-H, and Chairman of the Board for Bone Index Finland Ltd. Educated at Cornell University with a Bachelor's degree in Microbiology, Michael has a proven track record in fundraising, business development, and commercialization strategies.